Skip to main content

Table 2 rebleeding associated factors by univariate and multivariate COX regression analysis in cirrhotic patients

From: Influence of subcutaneous adipose tissue index on prognosis in cirrhotic patients following endoscopic therapy: a retrospective cohort study

Characteristics

Univariate

p-value

Multivariate

(SATI)

p-value

Multivariate

(Low SATI)*

p-value

HR (95%CI)

HR (95%CI)

HR (95%CI)

Age

0.986(0.968–1.005)

0.149

    

Gender

1.402(0.898–2.190)

0.137

    

Etiologic cause

Hepatitis B

1.177(0.769–1.803)

0.453

    

Hepatitis C

1.878(0.818–4.315)

0.137

    

Alcohol

1.083(0.543–2.161)

0.821

    

Autoimmune

0.856(0.395–1.858)

0.695

    

Others

0.694(0.412–1.168)

0.169

    

Laboratory date

Hemoglobin

0.991(0.977–1.005)

0.223

    

Platelet count

0.999(0.995–1.003)

0.671

    

Total bilirubin

1.014(0.996–1.031)

0.125

    

Serum albumin

0.929(0.886–0.974)

0.002

    

PT

1.051(0.939–1.175)

0.388

    

Child-Pugh score

1.322(1.166-1.500)

< 0.001

1.288(1.127–1.473)

< 0.001

1.262(1.111–1.434)

< 0.001

MELD score

1.123(1.026–1.229)

0.012

    

PVT

0.914(0.576–1.451)

0.704

    

Ascites

2.169(1.397–3.367)

0.001

    

NSBBs used

0.506(0.330–0.770)

0.002

0.610(0.396–0.939)

0.025

0.605(0.393–0.933)

0.023

Body Composition

BMI

0.944(0.882–1.010)

0.093

    

SATI

0.976(0.966–0.987)

< 0.001

0.981(0.971–0.991)

< 0.001

  

VATI

0.986(0.975–0.998)

0.020

    

TATI

0.989(0.983–0.995)

< 0.001

    

Low SATI*

2.917(1.874–4.540)

< 0.001

  

2.511(1.604–3.932)

< 0.001

  1. Abbreviations: CI, confidence interval; HR, hazard ratio; PT, prothrombin time; MELD, Model For End Stage Liver Disease; PVT, portal vein thrombosis; NSBBs, nonselective beta-receptor blockers; BMI, body mass index; SATI, subcutaneous adipose tissue index; VATI, visceral adipose tissue index; TATI, total adipose tissue index
  2. *Defined as SATI < 30.15 cm2/m2 for male and < 39.82 cm2/m2 for female